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2Abstract
Zoonotic infections are a growing threat to global health. Chlamydia pneumoniae, a major 
human pathogen, is widespread in human populations causing acute respiratory disease and is 
associated with chronic disease. C. pneumoniae was first identified solely in human populations; 
however its host range now includes other mammals, marsupials, amphibians and reptiles. 
Australian koalas (Phascolarctos cinereus) are widely infected with two species of Chlamydia, 
C. pecorum and C. pneumoniae. Transmission of C. pneumoniae between animals and humans 
has not been reported; however two other chlamydial species, C. psittaci and C. abortus, are 
known zoonotic pathogens. We have sequenced the 1,241,024bp chromosome and a 7.5kb 
cryptic chlamydial plasmid of the koala strain of C. pneumoniae (LPCoLN) using the whole 
genome shotgun method. Comparative genomic analysis, including pseudogene and SNP 
distribution, and phylogenetic analysis of conserved genes and SNPs against the human isolates 
of C. pneumoniae show that the LPCoLN isolate is basal to human isolates. Thus we propose 
based on compelling genomic and phylogenetic evidence that humans were originally infected 
zoonotically by animal isolate(s) of C. pneumoniae which adapted to humans primarily through 
the processes of gene decay and plasmid loss, to the point where the animal reservoir is no longer 
required for transmission.
3Introduction
Zoonotic infections from wildlife were recently suggested to be the most significant growing 
threat to global health of all the emerging infectious diseases (16). Chlamydia comprises a group 
of obligate intracellular bacterial parasites responsible for a variety of diseases in humans and 
animals, including several zoonoses. In 1999, Everett et al. proposed a reassignment from the 
single genus Chlamydia into two genera, Chlamydia and Chlamydophila, based on apparent 
differential clustering of the 16S rRNA genes (10). This change has not been widely accepted by 
the chlamydial research community, thus reversion to the single genus Chlamydia was recently 
recommended (33). Accordingly, we use the Chlamydia nomenclature here. 
Chlamydia pneumoniae (previously known as TWAR) was first recognized as a distinct species 
in 1988 (6) and is widespread in human populations causing acute respiratory disease, with 
effective human-to-human transmission by aerosol (30). It has also been associated with several 
human chronic diseases, including asthma (35), atherosclerosis (41), stroke (9) and late onset 
Alzheimer’s disease (1). C. pneumoniae was initially identified solely in humans; however its 
host range is now the most cosmopolitan of all the chlamydiae, encompassing both warm and 
cold-blooded animals such as horses, koalas and other marsupials, amphibians and reptiles (3). 
Populations of the Australian koala (Phascolarctos cinereus) are widely infected with two 
species of Chlamydia: C. pecorum and C. pneumoniae (3). While C. pecorum infections are 
present at ocular and urogenital sites, C. pneumoniae infections are commonly found in the koala 
respiratory tract linked to symptoms of respiratory disease (40), which is consistent with acute 
human C. pneumoniae disease. Transmission of C. pneumoniae between animals and humans has 
4not been documented; however two other chlamydial species, C. psittaci and C. abortus, are well 
known zoonotic pathogens transmitted from birds and ruminants (21) that cause psittacosis, a 
life-threatening pneumonia, and abortion respectively. Here we propose on the basis of 
compelling genomic and phylogenetic evidence that C. pneumoniae, a major human pathogen 
that is essentially clonal, was originally derived from an animal source.
The genome sequences of four epidemiologically distinct human-derived C. pneumoniae isolates 
have previously been determined (18, 27, 31).  These isolates are perceived as being genetically 
homogenous; this is supported by fewer than 300 single nucleotide polymorphisms (SNPs) 
scattered around the chromosome in no discernible pattern (Fig. 1; Table 1). Such a degree of 
similarity between temporally and geographically disparate isolates supports a relatively recent 
clonal expansion of human C. pneumoniae isolates (26) but is otherwise uninformative for 
deciphering the evolutionary origin(s) of this pathogen. Accordingly, we sequenced the complete 
genome of the koala C. pneumoniae isolate LPCoLN, seeking molecular insight into host 
specificity, evolutionary origin and pathogenicity. 
Materials and Methods
The koala C. pneumoniae LPCoLN isolate was originally isolated from a nasal swab of a captive 
koala showing signs of respiratory illness. C. pneumoniae was detected by PCR and gene 
sequencing, and LPCoLN was grown in vitro in HEp-2 cell monolayers. No other bacterium or 
virus was recovered from the nasal swab.
5The complete genome sequence of C. pneumoniae LPCoLN was determined using the whole-
genome shotgun method (23). Physical and sequencing gaps were closed using a combination of 
primer walking, generation and sequencing of transposon-tagged libraries of large-insert clones, 
and multiplex PCR (36). Identification of putative protein-coding genes and annotation of the 
genome were performed as previously described (23). An initial set of coding sequences (CDSs) 
predicted to encode proteins was identified with GLIMMER (7). CDSs consisting of fewer than 
30 codons were eliminated. Frame-shift and point mutations were corrected or designated 
“authentic”, as previously described (23). Functional assignment, identification of membrane-
spanning domains, determination of paralogous gene families, and identification of regions of 
unusual nucleotide composition were performed as previously described (23). Sequence 
alignments were generated using the methods described previously (23). 
C. pneumoniae LPCoLN and the genomes of four previously sequenced human-derived C. 
pneumoniae isolates (18, 27, 31) (GenBank accession numbers: CWL029, AE001363; TW-183, 
AE009440;  AR39, AE002161 and J138, BA000008) were compared at the nucleotide level by 
suffix tree analysis using MUMmer (8) and the data parsed by custom Perl scripts. Predicted C. 
pneumoniae genes were compared by BLAST against the complete set of genes from other 
chlamydial genomes using an E-value cut-off of 10-5. Synteny and BLAST Score Ratio analyses 
were performed as previously described (25). 
High quality synonymous SNPs (sSNPs) were identified by comparing the predicted genes on 
the closed genome of C. pneumoniae strain AR39 with the LPCoLN genome sequence using 
6MUMmer (8). A polymorphic site was considered high quality when its underlying sequence 
comprised at least three sequencing reads with an average Phred quality score greater than 30 
(11). sSNPs in CWL029, TW183 and J138 were similarly identified although no assessment of 
quality could be made, as quality scores are not available for these genomes. Concatenated 
sSNPs for the individual C. pneumoniae isolates were further analyzed by the HKY85 method 
(13) with 200 bootstrap replicates, and the results used to generate an unrooted phylogenetic tree 
according to the PhyLM algorithms (12).
One hundred and eleven clusters of shared proteins, with a BLAST Score Ratio greater than, or 
equal to 0.8 (25), were identified between all C. pneumoniae isolates, C. pecorum E58 (Myers et 
al., unpublished), C. muridarum Nigg (27) (GenBank: AE002160), C. caviae GPIC (28) 
(GenBank: AE015925), C. psittaci 6BC (Myers et al., unpublished) and C. abortus S26/3 (39) 
(GenBank: CR848038). Protein clusters were aligned using ClustalX (37) and back translated 
into nucleotide alignments using TRANSALIGN, part of the EMBOSS software package (29). 
Concatenated aligned genes, spanning a total of 121,674 positions with a sequence similarity of 
82.2% and identity of 58.8% were further analyzed by the HKY85 method (13) with 200 
bootstrap replicates, and the results used to generate an unrooted phylogenetic tree according to 
the PhyLM algorithms (12).
Results
C. pneumoniae LPCoLN possesses a single, circular chromosome of 1,241,024 base pairs (bp), 
slightly larger (by approximately 10 kb) than the human-derived C. pneumoniae isolates. The 
7small cryptic chlamydial plasmid (7,655 bp) that is absent from all characterized human C. 
pneumoniae isolates, is present in the koala strain, and is highly conserved with previously 
published chlamydial plasmid sequences. LPCoLN has 1,095 predicted coding sequences 
(CDSs), with 988 (90.2%) CDSs conserved with human C. pneumoniae isolate AR39, 14 (1.3%) 
divergent and 93 unique relative to AR39 (Fig. 1, Table 2). Most unique CDSs encode 
hypothetical proteins with no currently discernible function (Supplementary Table 1). 
Comparative genomic and proteomic analyses (25) show that the LPCoLN genome is highly 
similar and syntenic with the four sequenced human-derived isolates (Supplementary Fig. 1). 
However, unlike the small number of SNPs found between the human-derived isolates, 6213 
SNPs (3298 synonymous and 2915 non-synonymous) separate the genomes of LPCoLN and 
human isolate AR39 (Tables 1 & 3). Phylogenetic analysis of all C. pneumoniae isolates based 
on SNPs (Fig. 2) and 111 highly conserved genes from across all sequenced animal chlamydial 
genomes (Fig. 3) indicate that LPCoLN is basal to the sequenced C. pneumoniae isolates from 
humans.  Thus, while LPCoLN is a contemporary isolate, phylogeny places it closer to a 
presumptive ancestor of the C. pneumoniae isolates found in human populations. 
The genome-wide SNP distribution observed in the koala isolate compared to the human-derived 
isolates provides further evidence for a zoonotic origin of C. pneumoniae recovered from 
humans. There are ten noteworthy regions of SNP accumulation (Fig. 1 & 4), representing 
genomic “hotspots” that are likely evolving at different rates in C. pneumoniae from koalas and 
humans. Notably, many of the human isolates’ CDSs within these hotspots are truncated or 
8fragmented relative to LPCoLN, suggesting ongoing gene decay processes, with presumed 
concomitant loss of function in human-derived C. pneumoniae. Several of these hotspots encode 
known virulence or metabolic factors that display sequence polymorphisms and are variably 
represented in other chlamydial strains and species, including the polymorphic membrane protein 
(Pmp) family, secreted type III secretion (T3S) effectors, and enzymes involved in the 
biosynthesis of chorismate, a precursor of aromatic amino acids (Fig. 1 & 4). Gene truncation 
and fragmentation is also evident at several of these loci within the human-derived isolates, 
suggesting that microevolutionary processes are also ongoing in human C. pneumoniae.  Of the 
human isolates, CWL029 consistently exhibits a higher degree of gene truncation and 
fragmentation in several hotspots; AR39 shows the least, with TW-183 and J138 being 
intermediate.  
The largest SNP hotspot corresponds to the “plasticity zone” (PZ), a region that encapsulates 
much of the sequence diversity in all chlamydial genomes (28). The PZ, which has been shown 
to contain host and/or tissue specific genes in other chlamydial species (27, 28), appears to be 
fully intact in the koala isolate but is highly fragmented in all sequenced human-derived C. 
pneumoniae isolates. While many small CDSs appear to be unique to human-derived C. 
pneumoniae, comparison to LPCoLN reveals that several of these are actual remnants of four 
larger genes (Fig. 1) that are part of a previously unknown 11-member gene family encoding 
predicted membrane-bound proteins with predicted membrane spanning domains. 
There are only three genes of known function that are present in the human isolates and absent 
from LPCoLN: guaBA and add, required for the synthesis of guanosine 5'-monophosphate, a 
9precursor for the synthesis of guanine nucleoside triphosphates, located in the PZ of the human-
derived C. pneumoniae isolates. However, in three of the four human isolates, guaB is 
fragmented, indicating that it is presumably not essential for human infection. Such gene 
fragmentation patterns are only observed in the genomes of human isolates, and are only 
discernible by comparison to the koala LPCoLN genome. This unidirectional pattern of gene 
fragmentation seen throughout the human-derived C. pneumoniae genomes not only supports the 
phylogenetic analyses (Fig. 2 & 3), suggesting that animal-derived C. pneumoniae predates 
human-derived C. pneumoniae, but also suggests that animals were the original hosts for C. 
pneumoniae.
Discussion
Prior to this study, C. pneumoniae genome sequences were only available for four isolates, all of 
human origin. These genomes showed surprisingly high similarity, with an approximate total of 
only 300 SNPs between them.  Such a high degree of genomic conservation has been 
hypothesized to be evidence that C. pneumoniae was recently transmitted to humans followed by 
a rapid spread throughout human populations, giving little opportunity for genomic changes. 
This level of homology within C. pneumoniae is in contrast to the degree of genetic variability 
seen in the other chlamydial species, in particular C. trachomatis, which is thought to have 
infected humans throughout human evolution (4, 19, 32, 38). The host range of C. pneumoniae 
has been expanded significantly in the last 10 years with infections reported in horses (34), 
reptiles (3), amphibians (2, 3, 14) and several Australian marsupials, including koalas (40) and 
bandicoots (20).  Previous DNA sequence comparisons have focused on 16S rRNA and ompA 
genes. While these analyses have revealed differences between strains of human and animal 
origins, these differences have been minimal and relatively uninformative with regard to 
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determinants of host specificity. Our whole-genome analysis of the koala LPCoLN isolate of C. 
pneumoniae has enabled insight into the genetic differences between animal and human-derived 
C. pneumoniae, and the putative evolutionary events that have governed the spread of this 
organism, and shows that human isolates of C. pneumoniae exhibit more heterogeneity than 
previously thought.
The chlamydial cryptic plasmid is present in some chlamydial species, including C. pneumoniae 
N16 isolated from horses (24) but is absent from others. The role of the plasmid in chlamydial 
biology is still largely unknown. All human-derived C. pneumoniae isolates studied to date lack 
the plasmid, however, the koala isolate carries a full-length chlamydial plasmid, encoding all 
eight CDSs described in other chlamydial cryptic plasmids. Mitchell et al. (22) reported a much 
faster growth rate in vitro for the koala LPCoLN isolate compared to the human isolate AR39 - it 
is possible that one or more of the genes present on the cryptic plasmid may account for this 
faster growth rate. 
The most compelling evidence to support that LPCoLN is either ancestral, or closely related to 
an ancestral form of C. pneumoniae human isolates, is the presence of several putatively full-
length CDSs in LPCoLN, which are fragmented in human-derived C. pneumoniae, forming 
clusters of pseudogenes (Fig. 1 & 4). The MAC/perforin gene, which has been associated with 
virulence in other intracellular pathogens including Toxoplasma (17) and Plasmodium (15), is a 
2,457 bp CDS in LPCoLN, but is partially truncated in all four human-derived isolates due to an 
840 bp deletion towards the 5’ end. Although the function of chlamydial MAC/perforin is 
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currently unknown, we predict that it may be involved in host cell egression and invasion similar 
to Toxoplasma. The truncated version seen in the human isolates may then reflect adaptation to a 
specific niche within humans.
All pmpE and pmpG orthologs are intact in the koala strain but are fragmented in several of the 
human isolates (Fig. 1). The Pmp family of proteins is considered to represent the expansion of 
progenitor proteins proposed to be involved in key roles such as adherence, immune evasion and 
proinflammatory responses. In addition, orthologs of the Inc family of proteins are also 
extensively fragmented in the human isolates (Fig. 4). Inc proteins are a diverse family of 
chlamydial type III secreted effectors; incA has been localized to the outer face of the inclusion 
membrane and is involved in the homotypic fusion of multiple inclusions of C. trachomatis. The 
apparent ongoing loss of several functional pmp and inc genes in the human-derived isolates of 
C. pneumoniae again suggests an adaptation to the human host. It is conceivable that different 
Pmp and Inc profiles confer differential niche specificity in different hosts. The fragmentation of 
functional pmp and inc alleles in human-derived C. pneumoniae may therefore represent an 
example of convergent evolution of the two species in response to properties that are specific to 
humans (e.g. a more effective immune response against PmpE antigens in humans or the relative 
unavailability of cell surface receptors to PmpE in humans vs. koalas). 
Taken together, our analysis of the koala C. pneumoniae LPCoLN genome sequence, combined 
with phylogenetic analyses of all C. pneumoniae SNPs and the conserved chlamydial CDSs, the 
patterns of CDS fragmentation and plasmid loss in human-derived C. pneumoniae isolates 
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provides strong evidence that human isolates of C. pneumoniae have derived from zoonotic C. 
pneumoniae, supporting the conclusion of the selected SNP analysis of Rattei et al (26). Thus we 
propose that C. pneumoniae was originally an animal pathogen that crossed the species barrier to 
humans through ongoing reductive evolutionary processes and has adapted to the point where 
human isolates of C. pneumoniae no longer require an animal reservoir for transmission.  
A limitation of our study is that it is based on the genome sequence of only one animal-derived 
C. pneumoniae isolate, the koala LPCoLN strain and of four human-derived C. pneumoniae 
isolates. Hence, key questions such as how many times has this host species jump occurred 
before terminal adaptation or from which specific animal host the human-derived C. pneumoniae 
actually originated cannot be addressed with this dataset alone.  In addition to the full genome 
sequence from the LPCoLN isolate of koala C. pneumoniae, we also obtained and analysed a 
second koala C. pneumoniae isolate, EBB. This isolate was obtained from a pharyngeal swab 
from a koala in a wild population from a geographically separate location than LPCoLN.  Nine 
genes were sequenced from the EBB isolate and in all cases the sequences were 100% identical 
to the sequences obtained from the koala C. pneumoniae LPCoLN isolate (data not shown).
The koala C. pneumoniae LPCoLN isolate has been relatively well characterized previously in 
regards to morphological and in vitro growth characteristics. Coles et al. (5) reported that 
LPCoLN produced large inclusions in both human and koala monocytes and in HEp-2 cells. 
Koala C. pneumoniae was able to induce foam cell formation both with and without added low-
density lipoprotein, in contrast to TW183, which produced increased foam cell formation only in 
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the presence of low-density lipoprotein.  More recently, Mitchell et al. (22) compared the in vitro 
growth characteristics of LPCoLN with the human isolate AR39. LPCoLN displayed inclusions 
of size and morphology clearly distinct from those of the human isolate, and had a much faster 
doubling time (3.4-4.9 hr versus 5.9-8.7 hr) when grown in HEp2 cell monolayers. Rates of 
inclusion fusion were also much higher with LPCoLN (100%) than with AR39 (30-40%). These 
biological differences between koala and human-derived C. pneumoniae are consistent with the 
range of genomic differences that we have identified in this work. Such phenotypic studies 
demonstrate the compensatory power of comparative pathogenomics in a genetically intractable 
organism such as C. pneumoniae. Moreover the ability to compare genome sequences of 
organisms infecting different hosts provides “snapshots” of the evolutionary process as if frozen 
in time. The search is now on to find C. pneumoniae isolates from animals that are most closely 
related to human-derived isolates, as this will better indicate when this host species jump may 
have occurred.
Our findings indicate that the high prevalence and disease burden of C. pneumoniae in humans 
may represent a major evolutionary and public health corollary of zoonotic infections - the 
emergence of a full-fledged human pathogen, transmitted without the original animal vector, 
causing substantial acute and chronic disease sequelae. 
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Figure 1. Comparative analysis of sequenced C. pneumoniae genomes. Circular representation 
of C. pneumoniae genomes and analyses. For each genome, data are from outermost circle to 
innermost. Circles 1 and 2: Tick marks represent predicted coding sequences on the plus strand 
of C. pneumoniae AR39 and minus strand respectively, colored by cellular role. Role categories 
and colors are as follows: amino acid biosynthesis, violet; biosynthesis of cofactors, prosthetic 
groups and carriers, light blue; cell envelope, light green; cellular processes, red; central 
intermediary metabolism, brown; DNA metabolism, gold; energy metabolism, light gray; fatty 
acid and phospholipid metabolism, magenta; protein synthesis and fate, pink; biosynthesis of 
purines, pyrimidines, nucleosides and nucleotides, orange; regulatory functions and signal 
transduction, olive; transcription, dark green; transport and binding proteins, blue-green; other 
categories, salmon; unknown function, gray; conserved hypothetical proteins, blue; hypothetical 
proteins, black; Circles 3 and 4: Histogram of cumulative SNP density on the plus and minus 
strands respectively of the LPCoLN genome compared to AR39, using a 5000bp window. 
Histogram coloring: <30 SNPs, red; 20-29 SNPs, orange; 10-19 SNPs, yellow; 0-9 SNPs, light 
blue. Circles 5 and 6: Tick marks represent SNP locations on the plus (green) and minus (red) 
strands respectively of the LPCoLN genome. Circles 7 and 8: Tick marks represent SNP 
locations on the plus (green) and minus (red) strands respectively of the TW183 genome. Circles 
9 and 10: Tick marks represent SNP locations on the plus (green) and minus (red) strands 
respectively of the J138 genome. Circles 11 and 12: Tick marks represent SNP locations on the 
plus (green) and minus (red) strands respectively of the CWL-029 genome. Ten regions of high 
SNP accumulation in the LPCoLN genome versus AR39 are marked with light blue radial 
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sections and numbered. Callouts: Detail of high SNP accumulation in regions III and VI, 
showing SNP location and type (synonymous, green; non-synonymous, red) within PMP clusters 
(from left to right, LPCoLN gene region: ORF00989 to ORF00956; AR39 gene region: CP_0280 
to CP_0309) and the PZ (LPCoLN gene region: ORF00689 to ORF00665; AR39 gene region: 
CP_0585  to CP_0622) respectively. Regions highlighted with gray boxes show SNP-associated 
CDS fragmentation.
Figure 2. Synonymous SNP phylogenetic tree using all sequenced C. pneumoniae genomes. The 
number of separating sSNPs is denoted on each branch.
Figure 3. Phylogeny of all animal chlamydiae and C. pneumoniae, using 111 highly conserved 
gene clusters. The host range for each species is noted in parentheses; the known chlamydial 
zoonotic agents are boxed. The bootstrap value at each branch point is 100% unless otherwise 
denoted.
Figure 4. Annotated detail of additional regions shown in Figure 1 with high SNP accumulation, 
showing SNP location and type (synonymous, green; non-synonymous, red). Colours are used to 
distinguish notable annotated genes in each region. Regions highlighted with gray boxes show 
SNP-associated CDS fragmentation. The icon to the left of each region denotes the approximate 
location of each region as shown in Figure 1. 
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Table 1. Total SNPs in sequenced C. pneumoniae genomes, using C. pneumoniae AR39 as 
reference.
Isolate Host species # synonymous SNPS # non-synonymous SNPs Total SNPs
TW-183 Homo sapiens 120 164 284
CWL029 Homo sapiens 120 154 274
J138 Homo sapiens 62 145 207
LPCoLN Phascolarctos 
cinereus
3298 2915 6213
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Table 2. Breakdown of predicted protein orthologs in all human-derived C. pneumoniae 
genomes, compared to C. pneumoniae LPCoLN using the Blast Score Ratio method (25).
Conserved (≥0.5) Unique (≤0.4) Divergent (< 0.5 & > 0.4) Total 
LPCoLN vs. AR39 988 93 14 1095
LPCoLN vs. TW138 989 93 13 1095
LPCoLN vs. CWL029 955 127 13 1095
LPCoLN vs. J138 982 98 15 1095
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Table 3. Total (a) Synonymous and (b) Nonsynonymous SNPs identified between C. 
pneumoniae genomes, showing shared (italics) and separating unique (bold) SNPs. SNPs were 
identified in three-way genome comparisons in respect to the CDS of the reference strain C. 
pneumoniae AR39.  The individual branch lengths of the separating SNPs are given in 
parenthesis.
(a)
AR39 LPCoLN TW-183 CWL029 J138 
LPCoLN 2969 47 43 6
TW-183 105 2980 (2922/58) 41 3
CWL029 103 2986 (2926/60) 126 (64/62) 6
J138 58 3015 (2963/52) 157 (102/55) 149 (97/52)  
(b)
AR39 LPCoLN TW-183 CWL029 J138 
LPCoLN 2435 80 70 18
TW-183 144 2419 (2355/64) 70 17
CWL029 125 2420 (2365/70) 123 (71/51) 17
J138 128 2527 (2417/1100 238 (127/111) 219 (108/111)
